biotinylatedoligonucleotidebas
method
use
isol
subgenom
mrna
coronaviru
transmiss
gastroenter
viru
tgev
investig
amount
mrna
produc
earli
middl
late
time
replic
cycl
tgev
mrna
encod
n
protein
observ
abund
speci
throughout
replic
cycl
ratio
mrna
mrna
mrna
mrna
mrna
h
postinfect
mrna
speci
differenti
regul
throughout
replic
cycl
although
rate
accumul
mrna
mrna
increas
markedli
toward
end
replic
cycl
mrna
detect
system
use
observ
correl
amount
mrna
synthesis
potenti
degre
base
pair
end
leader
sequenc
transcript
associ
sequenc
genom
rna
time
replic
cycl
indic
extent
base
pair
factor
involv
control
subgenom
mrna
synthesi
transmiss
gastroenter
viru
tgev
member
genu
coronaviru
famili
coronavirida
envelop
viru
singlestrand
positivesens
rna
genom
approxim
nucleotid
nt
cap
polyadenyl
least
six
virusspecif
subgenom
mrna
speci
produc
tgevinfect
cell
form
nest
set
jacob
et
al
wesley
et
al
page
et
al
although
mrna
contain
one
gene
gene
present
next
smallest
mrna
translat
coronaviru
gene
genom
rna
preced
nontransl
region
vari
length
intergen
sequenc
lai
negativestrand
copi
genom
rna
intergen
sequenc
may
act
initi
site
transcript
subgenom
mrna
paper
shall
refer
sequenc
involv
synthesi
mrna
transcript
associ
sequenc
tass
addit
virusspecif
mrna
subgenom
negativestrand
rna
correspond
respect
subgenom
mrna
identifi
cell
infect
tgev
sethna
et
al
bovin
coronaviru
bcv
hofmann
et
al
mous
hepat
viru
mhv
sawicki
sawicki
tgev
shown
contain
antilead
sequenc
end
short
poli
u
sequenc
end
sethna
et
al
sethna
et
al
role
subgenom
negativestrand
rna
still
understood
author
indic
play
import
role
coronaviru
mrna
synthesi
sethna
et
al
sawicki
sawicki
other
play
small
role
end
product
transcript
andor
replic
process
jeong
makino
transcript
strategi
coronavirus
complex
present
complet
understood
date
leaderprim
hypothesi
predominantli
use
explain
origin
subgenom
mrna
transact
leader
rna
deriv
end
negativestrand
copi
genom
rna
recognis
conserv
sequenc
negativestrand
genom
rna
transcript
subgenom
mrna
lai
stohlman
yokomori
et
al
conserv
sequenc
tass
found
proxim
coronaviru
gene
though
sequenc
vari
differ
coronavirus
even
differ
gene
coronaviru
gener
coronaviru
mrna
synthesis
decreas
amount
size
speci
increas
lai
et
al
shieh
et
al
howev
analysi
mrna
speci
usual
singl
time
point
replic
cycl
either
metabol
label
northern
hybrid
produc
tgev
group
coronavirus
tgev
jacob
et
al
sethna
et
al
page
et
al
porcin
respiratori
coronaviru
prcv
felin
infecti
periton
viru
fipv
de
groot
et
al
canin
eoronaviru
ccv
horsburgh
et
al
indic
synthes
amount
invers
relat
length
impli
may
control
mechan
transcript
particular
mrna
leader
rna
sequenc
tgev
strain
purdu
nt
long
sethna
et
al
sequenc
data
indic
tgev
leader
rna
recognis
minim
sequenc
cuaaac
proxim
gene
tabl
analysi
subgenom
mrna
cell
infect
tabl
comparison
tgev
ta
site
mrna
intergen
sequenc
base
junction
pair
sm
n
uaaguuacuaaacuuugguaaccacuucguuaacacaccaug
uuaagaacuaaacuuucaagucauuacagguccu
guaug
ggcgguucuaaacgaaauugacuuaaaagaagaagagggag
accguaccuaug
guuugaacuaaacaaaaug
gguauaacuaaacuucuaaaug
uaacgaacuaaacgagaug
note
sequenc
underlin
tass
show
nucleotid
potenti
base
pair
end
leader
rna
initi
codon
respect
gene
boldfac
end
leader
rna
acucgaacuaaac
determin
page
et
al
mrna
speci
encod
tgev
structur
protein
indic
miller
strain
tgev
show
presenc
addit
mrna
speci
mrna
postul
synthesis
ta
cuaaac
proxim
potenti
tgev
gene
wesley
et
al
mrna
prcv
variant
tgev
observ
smaller
equival
tgev
mrna
due
loss
origin
ta
found
upstream
tgev
creation
new
ta
acuaaac
upstream
prcv
strain
gene
ratio
prcv
mrna
appear
similar
observ
tgev
amount
prcv
mrna
similar
amount
tgev
mrna
produc
ta
proxim
potenti
tgev
gene
higher
amount
observ
miller
mrna
differ
ta
mrna
tgev
miller
strain
prcv
mrna
presenc
extra
adenosin
nt
end
acuaaac
sequenc
prcv
interestingli
ta
mrna
sequenc
cuaaac
mrna
strain
tgev
sequenc
date
observ
produc
lower
amount
tgev
mrna
observ
indic
base
pair
tgev
tass
leader
rna
might
play
role
control
mrna
transcript
investig
whether
individu
tgev
mrna
speci
produc
specif
time
replic
cycl
correl
extent
leaderta
base
pair
amount
mrna
produc
earli
middl
late
time
point
tgev
strain
grown
llcpk
cell
medium
contain
eagl
mem
icn
flow
tryptos
phosphat
broth
difco
yeast
extract
sodium
bicarbon
unitsml
penicillin
xgml
streptomycin
unitsml
mycostatin
mm
n
ethanesulphon
acid
hepe
sigma
xgml
trypsin
difco
hofmann
wyler
viru
titrat
plaqu
assay
flask
cm
llcpk
cell
inocul
tgev
moi
incub
h
cell
wash
incub
fresh
medium
hourli
interv
h
pi
medium
remov
flask
replac
medium
contain
xgml
actinomycin
calbiochem
mbqml
uridin
nendupont
tbqmm
h
total
cellular
rna
isol
use
method
chomczynski
sacchi
oligonucleotid
biotingtatatcactatcaaaaggaaaa
complementari
end
tgev
genom
britton
et
al
synthes
appli
biosystem
dna
synthes
purifi
gel
electrophoresi
sambrook
et
al
biotin
residu
incorpor
end
use
biotinphosphoramidit
cruachem
streptavidin
magnet
bead
prepar
wash
naoh
follow
naci
bindingwash
bw
buffer
mm
trishcl
ph
mm
edta
naci
oligonucleotid
pmol
coupl
mg
streptavidin
magnet
bead
bw
buffer
min
room
temperatur
unbound
oligonucleotid
remov
wash
bead
bw
buffer
total
cellular
rna
xg
isol
tgevinfect
cell
made
ssc
sd
ssc
trisodium
citrat
ph
heat
rain
cool
ice
ad
magnet
beadsoligonucleotid
complex
incub
room
temperatur
h
rnamagnet
bead
complex
wash
ssc
sd
tgev
label
rna
elut
water
min
ethanol
precipit
purifi
tgev
label
rna
denatur
glyoxal
separ
agaros
gel
describ
sambrook
et
al
gel
soak
sodium
salicyl
bdh
min
enhanc
radioact
signal
chamberlain
dri
onto
whatman
paper
expos
preflash
xray
film
day
autoradiograph
align
gel
use
glogo
tm
ii
stratagen
autoradiograph
marker
determin
posit
tgev
mrna
speci
excis
gel
fix
onto
filtermat
membran
wallac
amount
radioact
determin
liquid
scintil
count
lkb
betapl
counter
number
count
mrna
speci
correct
number
uridin
residu
determin
sequenc
data
page
et
al
britton
et
al
amount
radioact
mrna
speci
correspond
molar
ratio
mrna
tgev
rna
isol
use
oligonucleotid
link
streptavidin
magnet
bead
elut
denatur
analys
agaros
gel
electrophoresi
preliminari
experi
shown
mg
streptavidin
magnet
bead
bound
pmol
biotinyl
oligonucleotid
oligonucleotid
magnet
bead
bound
rna
indic
virtual
tgev
rna
remov
rna
sampl
rna
profil
fig
ib
correspond
expect
tgev
confirm
bound
materi
tgev
rna
evid
ribosom
rna
often
observ
unlabel
ghost
band
glyoxal
gel
fig
alter
rna
profil
background
level
radioact
possibl
result
incorpor
uridin
cellular
rna
breakdown
product
incomplet
tgev
transcript
greatli
reduc
purifi
rna
fig
result
show
method
gave
purifi
tgev
mrna
suitabl
accur
quantit
determin
amount
tgev
mrna
genom
mrna
mrna
genom
mrna
mrna
mrna
mrna
mrna
fig
fluorograph
tgev
rna
follow
denatur
separ
agaros
gel
electrophoresi
lane
total
cellular
rna
lane
b
follow
purif
direct
hybrid
method
rna
hybrid
magnet
beadoligonucleotid
complex
min
elut
gel
soak
sodium
salicyl
dri
onto
whatman
paper
autoradiograph
investig
product
tgev
mrna
speci
earli
middl
late
time
point
replic
cycl
infect
cell
label
uridin
h
period
h
h
pi
mrna
speci
purifi
use
oligonucleotid
link
streptavidin
magnet
bead
amount
radioact
incorpor
speci
time
period
determin
experi
carri
three
time
interest
investig
whether
tgev
mrna
speci
preferenti
synthesis
particular
time
point
replic
cycl
whether
accumul
steadili
increas
rate
throughout
cycl
previou
work
character
tgev
mrna
investig
amount
mrna
produc
h
pi
use
either
metabol
label
northern
blot
hybrid
method
indic
final
amount
accumul
throughout
replic
cycl
three
experi
gave
similar
result
mean
valu
standard
deviat
present
fig
result
show
mrna
hour
post
infect
hour
post
infect
fig
analysi
amount
tgev
mrna
produc
throughout
replic
cycl
hourli
interv
h
pi
tgevinfect
llcpk
cell
label
uridin
h
total
rna
extract
tgev
rna
purifi
direct
hybrid
method
subgenom
mrna
separ
denatur
agaros
gel
electrophoresi
excis
gel
amount
radioact
measur
count
correct
number
uridin
residu
mrna
result
obtain
mrna
shown
mrna
b
point
repres
mean
valu
n
three
experi
n
bar
repres
standard
deviat
calcul
use
tr
n
abundantli
produc
mrna
time
point
replic
cycl
amount
measur
cpmuridin
residu
increas
approxim
threefold
h
repres
incorpor
label
h
pi
h
pi
repres
incorpor
label
h
pi
fig
accumul
rate
increas
markedli
h
pi
amount
rate
accumul
subgenom
mrna
h
label
period
h
pi
vari
depend
speci
amount
mrna
twofold
mrna
except
mrna
h
pi
amount
synthesis
later
time
point
slightli
increas
observ
decreas
h
pi
fig
amount
mrna
produc
h
pi
slightli
increas
though
overal
increas
two
time
point
fig
howev
note
amount
mrna
probabl
overestim
time
point
comigr
degrad
genom
rna
fig
rate
total
amount
mrna
produc
h
pi
follow
differ
pattern
mrna
speci
amount
mrna
produc
increas
time
period
appear
increas
amount
observ
h
pi
h
pi
point
amount
produc
increas
continu
increas
h
pi
fig
amount
mrna
produc
increas
h
pi
consist
increas
h
pi
rate
product
remain
almost
constant
h
pi
increas
h
pi
fig
mrna
detect
indic
amount
mrna
level
detect
though
northern
blot
analysi
detect
low
level
mrna
previou
studi
jacob
et
al
page
et
al
amount
mrna
speci
produc
h
pi
observ
decreas
indic
h
pi
time
point
end
replic
cycl
result
indic
tgev
mrna
speci
detect
system
synthesis
throughout
replic
cycl
though
mrna
appear
preferenti
synthesis
h
pi
respect
mrna
observ
increas
h
pi
although
product
mrna
speci
increas
amount
throughout
cycl
may
reflect
increas
amount
genom
antigenom
rna
amount
mrna
surprisingli
reflect
increas
addit
analys
amount
genom
rna
produc
throughout
replic
cycl
complet
sequenc
data
tgev
polymeras
gene
calcul
number
uridin
residu
nt
sequenc
polymeras
gene
previous
determin
number
uridin
residu
form
total
residu
valu
similar
determin
mrna
indic
total
number
uridin
residu
genom
rna
assum
genom
size
kb
amount
fulllength
genom
rna
cpmuridin
residu
rang
h
h
h
post
infect
indic
least
abund
rna
speci
amount
produc
appear
slowli
increas
throughout
replic
cycl
howev
amount
genom
rna
underestim
due
isol
degrad
genom
rna
rang
size
kb
mrna
full
length
allow
amount
genom
rna
synthesis
probabl
region
observ
mrna
observ
sethna
et
al
previou
work
mhv
budzilowicz
et
al
shieh
et
al
propos
extent
base
pair
tass
end
leader
rna
control
subgenom
mrna
abund
provid
explan
mhv
mrna
abund
subgenom
mrna
mhvinfect
cell
compar
amount
tgev
mrna
speci
produc
throughout
replic
cycl
degre
base
pair
tass
end
leader
rna
sequenc
determin
correl
respect
amount
mrna
speci
produc
comparison
indic
obviou
correl
base
pair
amount
mrna
synthesis
mrna
abund
speci
tgevinfect
cell
base
pair
nt
wherea
least
abund
mrna
mrna
undetect
system
base
pair
nt
mrna
observ
produc
similar
amount
earli
infect
later
mrna
increas
mrna
mrna
base
pair
nt
respect
howev
could
argu
mrna
twice
length
mrna
would
expect
produc
lower
amount
observ
mhv
aim
studi
investig
amount
tgev
mrna
produc
throughout
replic
cycl
determin
whether
mrna
synthesis
earlier
cycl
speci
whether
rate
accumul
mrna
constant
give
rise
dissimilar
amount
rna
b
investig
whether
correl
amount
mrna
produc
degre
base
pair
ta
sequenc
end
leader
rna
analysi
sequenc
preced
tgev
gene
indic
might
correl
number
nt
involv
base
pair
end
leader
rna
sequenc
tass
howev
also
possibl
mrna
speci
produc
preferenti
differ
time
viru
replic
cycl
analysi
rna
late
time
point
might
given
fals
impress
amount
mrna
thu
reproduc
effici
purif
method
allow
accur
analysi
amount
tgev
subgenom
mrna
produc
throughout
replic
cycl
requir
develop
method
made
use
biotinyl
tgevspecif
oligonucleotid
conjunct
streptavidin
magnet
bead
result
isol
tgev
mrna
free
ribosom
cellular
rna
major
potenti
breakdown
product
incomplet
transcript
deriv
tgev
rna
previou
attempt
isol
tgev
mrna
use
either
polydt
oligodu
column
chromatographi
result
contamin
ribosom
rna
potenti
affect
migrat
isol
mrna
use
oligodt
du
chromatographi
requir
multipl
purif
step
reduc
amount
contamin
rna
result
loss
mrna
multipl
purif
step
result
purif
smaller
mrna
loss
larger
speci
wash
step
ekenberg
et
al
previou
isol
method
also
result
differenti
background
level
radioact
possibl
result
incorpor
label
cellular
rna
incomplet
tgev
rna
transcript
breakdown
tgev
rna
result
inaccuraci
quantit
determin
analysi
amount
tgev
subgenom
mrna
confirm
differenti
regul
result
indic
particular
mrna
speci
produc
part
replic
cycl
howev
amount
mrna
speci
increas
significantli
variou
time
point
led
conclus
tempor
control
mechan
regul
product
mrna
possibl
mrna
previous
detect
low
amount
h
pi
preferenti
produc
earli
infect
subsequ
degrad
rna
howev
evid
studi
support
unless
mrna
produc
h
pi
rapidli
degrad
surprisingli
data
indic
although
mrna
initi
produc
low
amount
similar
level
observ
mrna
amount
increas
approxim
twofold
later
replic
cycl
leaderprim
model
coronaviru
transcript
reli
neg
sens
copi
genom
rna
variou
mrna
transcrib
amount
templat
synthesi
mrna
theoret
allow
synthesi
equival
quantiti
mrna
theori
smaller
particular
mrna
product
could
produc
activ
transcriptas
equival
mrna
observ
mrna
produc
differ
amount
even
produc
differenti
amount
replic
cycl
impli
control
transcript
leader
rna
recognis
ta
sequenc
via
complementar
simplest
control
mechan
may
result
differ
number
nt
involv
base
pair
leader
rna
ta
analysi
tgev
tass
identifi
differ
degre
base
pair
tabl
howev
comparison
amount
mrna
speci
produc
reveal
particular
pattern
observ
indic
base
pair
ta
leader
rna
play
role
control
synthesi
mrna
regulatori
factor
recent
result
analysi
tass
mhv
mrna
site
direct
mutagenesi
use
defect
interf
di
rna
system
van
der
et
al
indic
extent
base
pair
leader
rna
ta
control
subgenom
rna
abund
ta
recognit
depend
entir
base
pair
leader
sequenc
base
pair
respons
partial
involv
control
transcript
control
mechan
taken
account
eg
distanc
mrna
ta
initi
codon
gene
product
tabl
budzilowicz
et
al
hypothes
distanc
mhv
tass
initi
codon
gene
product
may
also
influenc
transcript
regul
amount
particular
mrna
may
relat
amount
natur
gene
product
impli
gene
product
could
neg
posit
control
mrna
synthesi
exampl
abund
coronaviru
mrna
encod
n
protein
case
except
tgev
group
coronavirus
smallest
mrna
produc
protein
probabl
requir
throughout
replic
cycl
protect
newli
synthes
rna
degrad
compton
et
al
assembl
nucleocapsid
addit
increas
synthesi
toward
end
replic
cycl
provid
enough
n
protein
incorpor
progeni
viru
contrast
least
abund
coronaviru
mrna
potenti
encod
product
produc
small
amount
exampl
gene
product
tgev
mrna
sm
detect
cell
surfac
late
stage
replic
cycl
molecul
per
virion
godet
et
al
observ
indic
sm
might
requir
small
amount
late
replic
cycl
consist
observ
increas
synthesi
mrna
h
pi
interestingli
synthesi
mrna
also
increas
late
replic
cycl
may
associ
requir
protein
incorpor
virion
initi
bud
nucleocapsid
morphogenesi
viru
particl
control
mechan
may
involv
degre
secondari
structur
neg
strand
around
ta
might
control
avail
ta
interact
leader
rna
involv
control
transcript
observ
coronavirus
also
produc
neg
copi
mrna
speci
antilead
sequenc
may
impli
mrna
may
also
synthesis
neg
copi
either
leaderprim
transcript
direct
replic
amount
mrna
produc
may
regul
avail
andor
amount
neg
copi
van
der
et
al
indic
transcriptas
complex
might
abl
recognis
sequenc
upstream
coronaviru
gene
without
involv
base
pair
impli
specif
proteinnucl
acid
interact
take
place
may
control
transcript
